Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily C Zabor

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological CorrelationsLaurence Albiges, A Ari Hakimi, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Cancer Causes & Control : CCC|January 19, 2017
Proceedings of the third international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Timothy R Rebbeck, Reiko Nishihara, et al.
Cancer Medicine|October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE StudyAmanda Nizam, Charles B Nguyen, Jinju Li, et al.
JAMA|April 20, 2023
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical TrialMichael I D'Angelica, Ryan J Ellis, Jason B Liu, et al.
Blood|July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological CorrelationsLaurence Albiges, A Ari Hakimi, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Cancer Causes & Control : CCC|January 19, 2017
Proceedings of the third international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Timothy R Rebbeck, Reiko Nishihara, et al.
Cancer Medicine|October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE StudyAmanda Nizam, Charles B Nguyen, Jinju Li, et al.
JAMA|April 20, 2023
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical TrialMichael I D'Angelica, Ryan J Ellis, Jason B Liu, et al.
Blood|July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Pageof 17